Comparative effectiveness research for prostate cancer radiation therapy: Current status and future directions

Xinglei Shen, Nicholas G. Zaorsky, Mark V. Mishra, Kathleen A. Foley, Terry Hyslop, Sarah Hegarty, Laura T. Pizzi, Adam P. Dicker, Timothy N. Showalter

Research output: Contribution to journalReview article

10 Scopus citations

Abstract

Comparative effectiveness research aims to help clinicians, patients and policymakers make informed treatment decisions under real-world conditions. Prostate cancer patients have multiple treatment options, including active surveillance, androgen deprivation therapy, surgery and multiple modalities of radiation therapy. Technological innovations in radiation therapy for prostate cancer have been rapidly adopted into clinical practice despite relatively limited evidence for effectiveness showing the benefit for one modality over another. Comparative effectiveness research has become an essential component of prostate cancer research to help define the benefits, risks and effectiveness of the different radiation therapy modalities currently in use for prostate cancer treatment.

Original languageEnglish (US)
Pages (from-to)37-54
Number of pages18
JournalFuture Oncology
Volume8
Issue number1
DOIs
StatePublished - Jan 1 2012

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Shen, X., Zaorsky, N. G., Mishra, M. V., Foley, K. A., Hyslop, T., Hegarty, S., Pizzi, L. T., Dicker, A. P., & Showalter, T. N. (2012). Comparative effectiveness research for prostate cancer radiation therapy: Current status and future directions. Future Oncology, 8(1), 37-54. https://doi.org/10.2217/fon.11.131